Say Goodbye to Migraines!
Say goodbye to debilitating migraines and headache attacks. Now there’s GelStat Migraine. Validated in clinical tests, and praised by customers.
GelStat is focused on the development and marketing of innovative over-the-counter (OTC) consumer healthcare products. The Company’s first two products, GelStat™ Migraine and GelStat™ Sleep are currently available direct-to-consumer. The Company’s third product GelStat™ Arthritis is fully developed and the Company expects to introduce it to the market place during the first half of 2011.
GelStat’s products have innovative formulations combined with uniquely advantageous delivery systems that provide consumers with clinically proven products that have improved efficacy, safety and convenience. In line with this strategy, two clinical trials have been conducted on GelStat™ Migraine, both yielding positive results.
The first was an open label study that was performed by Roger K. Cady, M.D. and Curtis P. Schreiber, M.D., both of ClinVest, the research division of the Headache Care Center in Springfield, Missouri. The second was a double blind study performed by Dr. Sheena K. Aurora. Dr. Aurora is a co-director of the Swedish Headache Center in Seattle, a specialty headache clinic that treats more than 3,000 patients each year. She is also board-certified in neurology and electro-diagnostic medicine as well as has additional qualifications in clinical neurophysiology. Equally important to the aforementioned studies, the Company has received a plethora of testimonials supporting the effectiveness of all three products.